Literature DB >> 26060202

QRS complex distortion (Grade 3 ischaemia) as a predictor of myocardial damage assessed by cardiac magnetic resonance imaging and clinical prognosis in patients with ST-elevation myocardial infarction.

Karl-Philipp Rommel1, Hadeel Badarnih1, Steffen Desch2, Matthias Gutberlet3, Gerhard Schuler1, Holger Thiele2, Ingo Eitel4.   

Abstract

AIMS: Distortion of the terminal portion of the QRS complex (so-called Grade 3 ischaemia, G3I) has been associated with adverse outcomes in ST-elevation myocardial infarction (STEMI) populations. However, the correlation of G3I with infarct size and microvascular injury as defined by cardiac magnetic resonance (CMR) is not well defined. Aim of this study was to assess the relation of G3I with myocardial damage as assessed by CMR and clinical outcomes in STEMI patients. METHODS AND
RESULTS: We analysed the ECGs of 572 consecutive STEMI patients regarding the presence or absence of G3I. CMR was performed within 1 week after infarction for comprehensive assessment of myocardial damage using a standardized protocol. The primary clinical endpoint was major adverse cardiac events (MACE) within 12 months after infarction. G3I was present in 186 (32%) patients. The presence of G3I was associated with larger infarct size (P = 0.01), the presence of late microvascular obstruction (P = 0.05), the presence of intramyocardial haemorrhage (P = 0.04), and impaired myocardial salvage (P = 0.01). G3I was associated with a higher incidence of MACE (P = 0.01) and was identified as an independent predictor of MACE in Cox regression analysis (HR 2.19; 95% CI 1.10 to 4.38, P = 0.03).
CONCLUSION: This largest study to date correlating G3I on the admission ECG with CMR markers of myocardial damage demonstrates that G3I is significantly associated with infarct size, impaired myocardial salvage, and reperfusion injury in a reperfused STEMI population. Moreover, G3I was independently associated with MACE. CLINICALTRIALS.GOV: NCT00712101. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author 2015. For permissions please email: journals.permissions@oup.com.

Entities:  

Keywords:  cardiac magnetic resonance; electrocardiogram; myocardial infarction; prognosis

Mesh:

Substances:

Year:  2015        PMID: 26060202      PMCID: PMC4882879          DOI: 10.1093/ehjci/jev135

Source DB:  PubMed          Journal:  Eur Heart J Cardiovasc Imaging        ISSN: 2047-2404            Impact factor:   6.875


  31 in total

1.  Grade 3 ischemia on the admission electrocardiogram predicts rapid progression of necrosis over time and less myocardial salvage by primary angioplasty.

Authors:  Therese Billgren; Charles Maynard; Timothy F Christian; Mohmmad A Rahman; Mahammad Saeed; Stephen C Hammill; Galen S Wagner; Yochai Birnbaum
Journal:  J Electrocardiol       Date:  2005-07       Impact factor: 1.438

2.  Determinants and prognostic implications of terminal QRS complex distortion in patients treated with primary angioplasty for acute myocardial infarction.

Authors:  C W Lee; M K Hong; H S Yang; S W Choi; J J Kim; S W Park; S J Park
Journal:  Am J Cardiol       Date:  2001-08-01       Impact factor: 2.778

3.  Predictors and implications of coronary infarct artery patency at initial angiography in patients with acute myocardial infarction (from the CADILLAC and HORIZONS-AMI Trials).

Authors:  Sorin J Brener; Roxana Mehran; Bruce R Brodie; Giulio Guagliumi; Bernhard Witzenbichler; Ecaterina Cristea; Ke Xu; Alexandra J Lansky; Gregg W Stone
Journal:  Am J Cardiol       Date:  2011-07-20       Impact factor: 2.778

4.  Grade 3 ischemia on the admission electrocardiogram is associated with severe microvascular injury on cardiac magnetic resonance imaging after ST elevation myocardial infarction.

Authors:  James C Weaver; David Rees; Ananth M Prasan; David D Ramsay; Maurits F Binnekamp; Jane A McCrohon
Journal:  J Electrocardiol       Date:  2011 Jan-Feb       Impact factor: 1.438

5.  Influences of electrocardiographic ischaemia grades and symptom duration on outcomes in patients with acute myocardial infarction treated with thrombolysis versus primary percutaneous coronary intervention: results from the DANAMI-2 trial.

Authors:  M Sejersten; Y Birnbaum; R S Ripa; C Maynard; G S Wagner; P Clemmensen
Journal:  Heart       Date:  2006-06-01       Impact factor: 5.994

6.  Site of transmural late gadolinium enhancement on the cardiac MRI coincides with the ECG leads exhibiting terminal QRS distortion in patients with ST-elevation myocardial infarctions.

Authors:  Asami Nimura; Naka Sakamoto; Naoki Nakagawa; Hisanobu Ota; Yasuko Tanabe; Toshiharu Takeuchi; Shunsuke Natori; Nobuyuki Sato; Naoyuki Hasebe; Yuichiro Kawamura
Journal:  Int Heart J       Date:  2012       Impact factor: 1.862

7.  Grade III ischemia on presentation with acute myocardial infarction predicts rapid progression of necrosis and less myocardial salvage with thrombolysis.

Authors:  Yochai Birnbaum; Kenneth W Mahaffey; Douglas A Criger; Kathy B Gates; Gabriel I Barbash; Alejandro Barbagelata; Peter Clemmensen; Elena B Sgarbossa; Raymond J Gibbons; M Atiar Rahman; Robert M Califf; Chistopher B Granger; Galen S Wagner
Journal:  Cardiology       Date:  2002       Impact factor: 1.869

8.  Prognostic significance of the initial electrocardiographic pattern in a first acute anterior wall myocardial infarction.

Authors:  Y Birnbaum; S Sclarovsky; A Blum; A Mager; U Gabbay
Journal:  Chest       Date:  1993-06       Impact factor: 9.410

9.  Prognostic significance of the admission electrocardiogram in acute myocardial infarction.

Authors:  Y Birnbaum; I Herz; S Sclarovsky; B Zlotikamien; A Chetrit; L Olmer; G I Barbash
Journal:  J Am Coll Cardiol       Date:  1996-04       Impact factor: 24.094

10.  ST-segment recovery and outcome after primary percutaneous coronary intervention for ST-elevation myocardial infarction: insights from the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial.

Authors:  Christopher E Buller; Yuling Fu; Kenneth W Mahaffey; Thomas G Todaro; Peter Adams; Cynthia M Westerhout; Harvey D White; Arnoud W J van 't Hof; Frans J Van de Werf; Galen S Wagner; Christopher B Granger; Paul W Armstrong
Journal:  Circulation       Date:  2008-09-08       Impact factor: 29.690

View more
  3 in total

1.  Ischemic QRS prolongation as a biomarker of myocardial injury in STEMI patients.

Authors:  Jakob Almer; Viktor Elmberg; Josef Bränsvik; David Nordlund; Ardavan Khoshnood; Michael Ringborn; Marcus Carlsson; Ulf Ekelund; Henrik Engblom
Journal:  Ann Noninvasive Electrocardiol       Date:  2018-09-28       Impact factor: 1.468

2.  Terminal QRS Distortion in ST Elevation Myocardial Infarction as a Prediction of Mortality: Systematic Review and Meta-Analysis.

Authors:  Narut Prasitlumkum; Natee Sirinvaravong; Nath Limpruttidham; Pattara Rattanawong; Elysse Tom; Chanavuth Kanitsoraphan; Pakawat Chongsathidkiet; Thosaporn Boondarikpornpant
Journal:  Acta Cardiol Sin       Date:  2019-09       Impact factor: 2.672

3.  Estimating the extent of myocardial damage in patients with STEMI using the DETERMINE score.

Authors:  Christina Tiller; Magdalena Holzknecht; Martin Reindl; Ivan Lechner; Verena Kalles; Felix Troger; Johannes Schwaiger; Agnes Mayr; Gert Klug; Christoph Brenner; Axel Bauer; Bernhard Metzler; Sebastian Johannes Reinstadler
Journal:  Open Heart       Date:  2021-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.